लोड हो रहा है...
Going Back to Class I: MHC and Immunotherapies for Childhood Cancer
After decades of unfulfilled promise, immunotherapies for cancer have finally reached a tipping point, with several FDA approved products now on the market and many more showing promise in both adult and pediatric clinical trials. Tumor cell expression of MHC Class I has emerged as a potential deter...
में बचाया:
| में प्रकाशित: | Pediatr Blood Cancer |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2014
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4339346/ https://ncbi.nlm.nih.gov/pubmed/25524394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25359 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|